Detection_NN of_IN Trichomonas_NP vaginalis_NNS on_IN Modified_NP Columbia_NP Agar_NP in_IN the_DT Routine_NP Laboratory_NP Broth_NP culture_NN of_IN Trichomonas_NP vaginalis_NN is_VBZ considered_VBN the_DT "_`` gold_JJ standard_NN "_'' for_IN the_DT diagnosis_NN of_IN trichomoniasis_NN ._SENT Two_CD studies_NNS were_VBD carried_VBN out_RP to_TO evaluate_VB modified_JJ Columbia_NP agar_NN (_( MCA_NP )_) for_IN the_DT isolation_NN of_IN T._NP vaginalis_NNS from_IN clinical_JJ samples_NNS ._SENT Study_VB I_PP compared_VBN isolation_NN on_IN MCA_NP to_TO that_DT on_IN liquid_JJ medium_NN with_IN 889_CD vaginal_JJ samples_NNS ._SENT Out_RB of_IN 63_CD samples_NNS positive_JJ for_IN T._NP vaginalis_NNS (_( 7.1_CD %_NN of_IN total_NN )_) ,_, MCA_NP identified_VBD 62_CD (_( 98.4_CD %_NN )_) and_CC broth_NN identified_VBN 58_CD (_( 92.1_CD %_NN )_) ._SENT In_IN study_NN II_NP ,_, trichomoniasis_NN was_VBD diagnosed_VBN within_IN the_DT scope_NN of_IN a_DT screening_NN program_NN for_IN a_DT total_NN of_IN 39,585_CD men_NNS and_CC women_NNS by_IN culture_NN on_IN MCA_NP and_CC direct_JJ microscopy_NN ._SENT Culture_NN on_IN MCA_NP detected_VBD 199_CD (_( 98.5_CD %_NN )_) and_CC Gram_NP staining_VBG detected_VBN 163_CD (_( 80.7_CD %_NN )_) of_IN 202_CD positive_JJ specimens_NNS ._SENT Wet-mount_NN preparations_NNS used_VBN for_IN symptomatic_JJ patients_NNS identified_VBD 103_CD (_( 92.8_CD %_NN )_) of_IN 111_CD cases_NNS ._SENT Culture_NN of_IN T._NP vaginalis_NNS from_IN clinical_JJ samples_NNS on_IN MCA_NP is_VBZ highly_RB sensitive_JJ and_CC reliable_JJ ,_, as_RB well_RB as_IN timesaving_JJ ,_, and_CC therefore_RB suitable_JJ for_IN screening_VBG of_IN symptomatic_JJ and_CC asymptomatic_JJ individuals_NNS ._SENT The_DT parasitic_JJ protozoan_JJ Trichomonas_NP vaginalis_NN is_VBZ a_DT common_JJ pathogen_NN that_WDT causes_VBZ trichomoniasis_NN and_CC has_VBZ been_VBN linked_VBN to_TO preterm_NN birth_NN ,_, acquisition_NN of_IN human_JJ immunodeficiency_NN virus_NN ,_, infertility_NN ,_, and_CC nongonococcal_JJ urethritis_NN ._SENT Males_NNS are_VBP most_RBS frequently_RB considered_VBN to_TO be_VB asymptomatic_JJ carriers_NNS ,_, which_WDT represent_VBP an_DT important_JJ vector_NN and_CC reservoir_NN ._SENT According_VBG to_TO the_DT population_NN studied_VBD ,_, the_DT prevalence_NN of_IN infection_NN in_IN females_NNS varies_VBZ from_IN 5_CD to_TO 50_CD %_NN in_IN patients_NNS attending_VBG sexually_RB transmitted_JJ disease_NN (_( STD_NN )_) clinics_NNS ._SENT Although_IN often_RB observed_VBN in_IN women_NNS with_IN vaginal_JJ symptoms_NNS ,_, trichomoniasis_NN may_MD be_VB asymptomatic_JJ in_IN up_IN to_TO 50_CD %_NN of_IN infected_JJ individuals_NNS ._SENT Hence_RB ,_, diagnosis_NN has_VBZ to_TO be_VB based_VBN on_IN laboratory_NN procedures_NNS ,_, such_JJ as_IN direct_JJ microscopy_NN and_CC culture_NN ._SENT Most_RBS frequently_RB ,_, the_DT saline_JJ wet-mount_NN preparation_NN is_VBZ used_VBN for_IN observation_NN of_IN motile_JJ organisms_NNS ._SENT Different_JJ staining_VBG techniques_NNS ,_, including_VBG those_DT using_VBG Gram_NP stain_NN ,_, Giemsa_NP stain_NN ,_, Papanicolaou_NP (_( Pap_NN )_) smear_NN ,_, and_CC acridine_NN orange_NN ,_, and_CC diverse_JJ molecularly_RB based_VBN diagnostic_JJ methods_NNS ,_, such_JJ as_IN hybridization_NN assay_NN and_CC PCR_NP ,_, have_VBP been_VBN employed_VBN to_TO detect_VB T._NP vaginalis_NNS but_CC vary_VBP widely_RB in_IN their_PP$ sensitivities_NNS and_CC specificities_NNS (_( ,_, ,_, -_: ,_, )_) ._SENT Thus_RB ,_, broth_NN culture_NN is_VBZ still_RB considered_VBN the_DT "_`` gold_JJ standard_NN "_'' for_IN diagnosis_NN of_IN trichomoniasis_NN ._SENT For_IN this_DT purpose_NN ,_, various_JJ liquid_JJ culture_NN media_NNS have_VBP been_VBN developed_VBN ._SENT However_RB ,_, identification_NN of_IN positive_JJ samples_NNS requires_VBZ frequent_JJ microscopic_JJ observations_NNS for_IN up_IN to_TO 7_CD days_NNS ._SENT To_TO evaluate_VB the_DT suitability_NN of_IN a_DT solid_JJ medium_NN cultivation_NN technique_NN in_IN the_DT routine_JJ laboratory_NN ,_, two_CD studies_NNS were_VBD carried_VBN out_RP ._SENT In_IN study_NN I_PP ,_, modified_JJ Columbia_NP agar_NN (_( MCA_NP )_) was_VBD compared_VBN to_TO a_DT commercially_RB available_JJ liquid_JJ medium_NN in_IN its_PP$ ability_NN to_TO support_VB trichomonal_JJ growth_NN from_IN clinical_JJ specimens_NNS ._SENT Subsequently_RB ,_, in_IN study_NN II_NP ,_, culture_NN on_IN MCA_NP and_CC direct_JJ microscopy_NN were_VBD used_VBN to_TO screen_VB a_DT low-risk_JJ population_NN for_IN T._NP vaginalis_NNS ._SENT Finally_RB ,_, the_DT reliabilities_NNS of_IN the_DT methods_NNS employed_VBN were_VBD determined_VBN ._SENT Study_NP I._NP |_SYM A_DT total_NN of_IN 889_CD women_NNS attending_VBG the_DT Outpatients_NP '_POS Center_NP in_IN Vienna_NP ,_, Austria_NP ,_, because_IN of_IN symptoms_NNS and/or_CC signs_NNS of_IN infections_NNS of_IN the_DT genital_JJ tract_NN ,_, or_CC for_IN contact_NN tracing_NN ,_, were_VBD included_VBN in_IN the_DT first_JJ study_NN period_NN between_IN 1994_CD and_CC 1995_CD ._SENT Four_CD swab_NN samples_NNS from_IN the_DT posterior_JJ vaginal_JJ fornix_NN were_VBD collected_VBN from_IN each_DT woman_NN and_CC processed_VBN at_IN the_DT bedside_NN ._SENT The_DT first_JJ two_CD swabs_NNS were_VBD used_VBN for_IN wet-mount_NN preparation_NN and_CC Gram_NP staining_VBG ,_, respectively_RB ._SENT Trichomonas_NP medium_NN and_CC finally_RB MCA_NP plates_NNS were_VBD inoculated_VBN with_IN the_DT third_JJ and_CC fourth_JJ samples_NNS ,_, respectively_RB ._SENT To_TO investigate_VB the_DT ability_NN of_IN broth_NN culture_NN and_CC MCA_NP plates_NNS to_TO grow_VB different_JJ concentrations_NNS of_IN T._NP vaginalis_NNS ,_, an_DT in_IN vitro_NN experiment_NN was_VBD performed_VBN ._SENT Standardized_JJ inocula_NNS of_IN 100_CD ,_, 101_CD ,_, 102_CD ,_, 103_CD ,_, and_CC 104_CD organisms_NNS per_IN ml_NN (_( final_JJ concentrations_NNS )_) were_VBD inoculated_VBN into_IN 5_CD and_CC 17_CD ml_NN of_IN trichomonas_NNS broth_NN as_IN well_RB as_RB onto_IN MCA_NP plates_NNS ._SENT For_IN quality_NN control_NN ,_, T._NP vaginalis_NN ATCC_NP 30001_CD was_VBD processed_VBN in_IN parallel_NN and_CC with_IN all_DT lots_NNS of_IN media_NNS produced_VBN ._SENT Study_NP II_NP ._SENT |_SYM Altogether_RB ,_, 39,585_CD individuals_NNS (_( 13,195_CD men_NNS and_CC 26,390_CD women_NNS )_) presenting_VBG at_IN the_DT STD_NN center_NN in_IN the_DT years_NNS between_IN 1996_CD and_CC 2000_CD for_IN routine_JJ microbiological_JJ examinations_NNS and_CC for_IN suspected_JJ infections_NNS of_IN the_DT genital_JJ tract_NN with_IN or_CC without_IN symptoms_NNS were_VBD screened_VBN for_IN T._NP vaginalis_NNS ._SENT Trichomoniasis_NN was_VBD diagnosed_VBN by_IN culture_NN on_IN MCA_NP and_CC by_IN Gram_NP staining_VBG of_IN vaginal_JJ samples_NNS from_IN women_NNS and_CC urethral_JJ specimens_NNS from_IN men_NNS ._SENT For_IN symptomatic_JJ patients_NNS ,_, immediate_JJ wet-mount_NN preparations_NNS were_VBD used_VBN ._SENT Specimens_NNS were_VBD sampled_VBN and_CC processed_VBN as_IN described_VBN above_IN ._SENT Cultivation_NN and_CC identification_NN ._SENT |_SYM Trichomonas_NP medium_NN (_( Oxoid_NP Ltd._NP ,_, Basingstoke_NP ,_, Hampshire_NP ,_, England_NP )_) was_VBD dissolved_VBN ,_, autoclaved_VBN ,_, and_CC mixed_VBN with_IN 10_CD %_NN sterile_JJ ,_, inactivated_VBD lamb_NN serum_NN (_( PAA_NP Laboratories_NP ,_, Linz_NP ,_, Austria_NP )_) ,_, 1_CD %_NN dextrose_NN (_( Sigma_NP Chemical_NP Co._NP ,_, St._NP Louis_NP ,_, Mo._NP )_) ,_, 1_CD %_NN malt_NN extract_NN (_( Oxoid_NP Ltd._NP )_) ,_, and_CC 1_CD ampoule_NN of_IN chloramphenicol_NN selective_JJ supplement_NN (_( Oxoid_NP Ltd._NP )_) ._SENT A_DT 17-ml_JJ volume_NN was_VBD dispensed_VBN into_IN tubes_NNS with_IN screw_NN caps_NNS to_TO ensure_VB anaerobic_JJ growth_NN conditions_NNS and_CC to_TO keep_VB organisms_NNS viable_JJ until_IN the_DT end_NN of_IN incubation_NN ._SENT MCA_NP was_VBD prepared_VBN as_RB follows_VBZ :_: 13_CD g_NN of_IN Columbia_NP agar_NN (_( Oxoid_NP Ltd._NP )_) was_VBD dissolved_VBN in_IN 320_CD ml_NN of_IN distilled_JJ water_NN ,_, and_CC the_DT solution_NN was_VBD adjusted_VBN to_TO a_DT pH_NN of_IN 6_CD ,_, cooked_VBN for_IN 20_CD min_NN ,_, autoclaved_VBN at_IN 121C_NP for_IN 5_CD min_NN ,_, and_CC cooled_VBN before_IN the_DT addition_NN of_IN 50_CD ml_NN of_IN sterile_JJ ,_, inactivated_VBD lamb_NN serum_NN (_( PAA_NP Laboratories_NPS )_) containing_VBG 4_CD g_NN of_IN dextrose_NN (_( Sigma_NP Chemical_NP Co._NP )_) ,_, 4_CD g_NN of_IN malt_NN extract_NN (_( Oxoid_NP Ltd._NP )_) ,_, 15_CD ml_NN of_IN Baneocin_NP (_( 250_CD U_NN of_IN bacitron/ml_NN and_CC 5,000_CD U_NN of_IN neomycin/ml_NN ;_: Biochemie_NP ,_, Vienna_NP ,_, Austria_NP )_) ,_, 10_CD ml_NN of_IN nystatin_NN solution_NN (_( 10,000_CD U/ml_NP ;_: Biochrom_NP KG_NP ,_, Berlin_NP ,_, Germany_NP )_) ,_, 4_CD ml_NN of_IN penicillin-streptomycin_NN solution_NN (_( 10,000_CD of_IN penicillin/ml_NN and_CC 10,000_CD mug_NN of_IN streptomycin/ml_NN ;_: Gibco_NP BRL_NP ,_, Life_NP Technologies_NPS ,_, Paisley_NP ,_, Scotland_NP )_) ,_, and_CC 1_CD ampoule_NN of_IN chloramphenicol_NN selective_JJ supplement_NN (_( Oxoid_NP Ltd._NP )_) ._SENT Approximately_RB 10_CD ml_NN of_IN the_DT resulting_VBG mixture_NN was_VBD poured_VBN into_IN 6-cm-diameter_JJ petri_NNS dishes_NNS ._SENT Both_DT media_NNS were_VBD stored_VBN at_IN 4C_JJ for_IN no_DT longer_JJR than_IN 1_CD week_NN and_CC allowed_VBD to_TO reach_VB room_NN temperature_NN before_IN use_NN ._SENT Immediate_JJ incubation_NN of_IN inoculated_VBN broth_NN and_CC agar_NN plates_NNS ,_, which_WDT were_VBD held_VBN under_IN anaerobic_JJ conditions_NNS (_( Anaerocult_JJ P_NN ;_: Merck_NP KgaA_NP ,_, Darmstadt_NP ,_, Germany_NP )_) ,_, was_VBD carried_VBN out_RP at_IN 37C_JJ for_IN 6_CD days_NNS ._SENT Identification_NN of_IN T._NP vaginalis_NNS was_VBD achieved_VBN by_IN observation_NN of_IN motile_JJ organisms_NNS in_IN wet-mount_NN preparations_NNS and_CC by_IN use_NN of_IN Gram-stained_JJ smears_NNS ._SENT Macroscopic_JJ evaluation_NN of_IN all_DT cultures_NNS for_IN turbidity_NN in_IN the_DT case_NN of_IN trichomonal_JJ growth_NN and_CC of_IN slide_NN preparations_NNS from_IN broth_NN cultures_NNS was_VBD performed_VBN regularly_RB ._SENT MCA_NP was_VBD examined_VBN microscopically_RB (_( magnification_NN ,_, x100_NP )_) ,_, and_CC results_NNS were_VBD confirmed_VBN by_IN using_VBG a_DT saline_JJ wet_JJ mount_NN ._SENT Colonies_NNS of_IN T._NP vaginalis_NNS on_IN MCA_NP cause_VBP a_DT change_NN of_IN pH_NN resulting_VBG in_IN a_DT muddy_JJ appearance_NN of_IN the_DT plates_NNS ._SENT The_DT characteristic_JJ puzzle-like_JJ structures_NNS caused_VBN by_IN trophozoites_NNS lying_VBG close_NN to_TO each_DT other_JJ can_MD be_VB observed_VBN most_RBS easily_RB at_IN the_DT edge_NN of_IN the_DT colony_NN ._SENT Study_NP I._NP |_SYM Out_RB of_IN the_DT 889_CD women_NNS enrolled_VBN in_IN study_NN I_PP ,_, a_DT total_NN of_IN 63_CD (_( 7.1_CD %_NN )_) were_VBD positive_JJ for_IN T._NP vaginalis_NNS by_IN direct_JJ microscopy_NN and/or_CC culture_NN ._SENT Growth_NN of_IN T._NP vaginalis_NNS was_VBD observed_VBN in_IN 58_CD (_( 92.1_CD %_NN )_) of_IN 63_CD samples_NNS in_IN broth_NN culture_NN and_CC in_IN 62_CD (_( 98.4_CD %_NN )_) of_IN 63_CD specimens_NNS in_IN culture_NN on_IN MCA_NP ,_, resulting_VBG in_IN an_DT overall_JJ accordance_NN of_IN 93.5_CD %_NN ._SENT Altogether_RB ,_, 10_CD (_( 17.2_CD %_NN )_) of_IN 58_CD positive_JJ cultures_NNS in_IN trichomonas_NNS broth_NN showed_VBD low_JJ numbers_NNS of_IN organisms_NNS ,_, whereas_IN 2_CD (_( 3.2_CD %_NN )_) of_IN 62_CD positive_JJ MCA_NP plates_NNS showed_VBD low_JJ numbers_NNS of_IN organisms_NNS ._SENT One_CD positive_JJ sample_NN was_VBD detected_VBN by_IN direct_JJ microscopy_NN only_RB ,_, while_IN this_DT method_NN missed_VBD a_DT total_NN of_IN six_CD infected_JJ samples_NNS that_WDT were_VBD identified_VBN by_IN culture_NN on_IN MCA_NP ._SENT With_IN broth_NN culture_NN ,_, three_CD of_IN these_DT samples_NNS were_VBD positive_JJ and_CC another_DT two_CD showed_VBD low_JJ numbers_NNS of_IN organisms_NNS ,_, leaving_VBG the_DT infection_NN in_IN one_CD specimen_NN not_RB detected_VBD ._SENT A_DT total_NN of_IN five_CD infections_NNS would_MD have_VB been_VBN missed_VBN if_IN broth_NN culture_NN only_RB had_VBD been_VBN performed_VBN ._SENT No_DT sample_NN positive_JJ on_IN liquid_JJ medium_NN but_CC negative_JJ on_IN MCA_NP plates_NNS was_VBD observed_VBN ._SENT In_IN vitro_NN experiment_NN ._SENT |_SYM MCA_NP plates_NNS were_VBD positive_JJ with_IN all_DT standardized_JJ inocula_NNS within_IN 6_CD days_NNS of_IN incubation_NN ._SENT After_IN 24_CD h_NN ,_, plates_NNS that_WDT had_VBD been_VBN inoculated_VBN with_IN 102_CD trichomonads_NNS per_IN ml_NN or_CC more_JJR were_VBD positive_JJ ,_, while_IN inocula_NNS of_IN 101_CD trichomonads_NNS gave_VBD positive_JJ results_NNS after_IN 72_CD h._NNS All_DT broth_NN cultures_NNS inoculated_VBN with_IN 100_CD ,_, 101_CD ,_, or_CC 102_CD trichomonads_NNS per_IN ml_NN stayed_VBD negative_JJ for_IN the_DT whole_JJ examination_NN period_NN ,_, regardless_RB of_IN the_DT volume_NN used_VBD ._SENT Both_CC the_DT 5-ml_JJ volume_NN and_CC the_DT 17-ml_JJ volume_NN showed_VBD positive_JJ results_NNS with_IN inocula_NNS of_IN 104_CD and_CC 103_CD trichomonads_NNS after_IN 24_CD and_CC 48_CD h_NN ,_, respectively_RB ._SENT Study_NP II_NP ._SENT |_SYM Screening_NP for_IN T._NP vaginalis_NNS performed_VBN with_IN a_DT total_NN of_IN 39,585_CD men_NNS and_CC women_NNS attending_VBG the_DT STD_NN center_NN identified_VBD 202_CD infected_JJ individuals_NNS (_( 7_CD men_NNS [_SYM 0.05_CD %_NN ]_SYM and_CC 195_CD women_NNS [_SYM 0.74_CD %_NN ]_SYM )_) ,_, revealing_VBG a_DT prevalence_NN of_IN 0.5_CD %_NN ._SENT Table_NN shows_VBZ the_DT results_NNS obtained_VBN for_IN all_DT specimens_NNS collected_VBD ._SENT Gram_NN staining_VBG of_IN smears_NNS and_CC culture_NN on_IN MCA_NP were_VBD performed_VBN to_TO detect_VB trichomonads_NNS in_IN both_DT asymptomatic_JJ and_CC symptomatic_JJ patients_NNS ._SENT Wet-mount_NN preparations_NNS were_VBD used_VBN for_IN samples_NNS from_IN 111_CD symptomatic_JJ patients_NNS (_( 3_CD men_NNS and_CC 108_CD women_NNS )_) ,_, or_CC 55_CD %_NN of_IN infected_JJ individuals_NNS ._SENT Culture_NN on_IN MCA_NP detected_VBD 199_CD (_( 98.5_CD %_NN )_) of_IN 202_CD infections_NNS in_IN symptomatic_JJ as_RB well_RB as_IN asymptomatic_JJ individuals_NNS ,_, with_IN sensitivities_NNS of_IN 100_CD and_CC 97.3_CD %_NN ,_, respectively_RB ._SENT Infections_NNS in_IN three_CD samples_NNS could_MD be_VB detected_VBN by_IN direct_JJ microscopy_NN only_RB ,_, that_IN in_IN one_CD specimen_NN was_VBD detected_VBN with_IN a_DT wet-mount_NN preparation_NN as_RB well_RB as_IN Gram_NP staining_VBG and_CC those_DT in_IN two_CD samples_NNS were_VBD detected_VBN by_IN using_VBG wet_JJ mount_NN exclusively_RB ._SENT Gram_NN staining_VBG identified_VBN 163_CD (_( 80.7_CD %_NN )_) of_IN 202_CD infected_JJ persons_NNS ,_, with_IN infections_NNS in_IN 12_CD symptomatic_JJ and_CC 27_CD asymptomatic_JJ individuals_NNS not_RB detected_VBN ._SENT For_IN 111_CD samples_NNS from_IN patients_NNS with_IN clinical_JJ symptoms_NNS ,_, wet-mount_NN preparations_NNS detected_VBD infections_NNS in_IN 103_CD (_( 92.8_CD %_NN )_) specimens_NNS but_CC failed_VBD to_TO detect_VB 8_CD positive_JJ specimens_NNS ,_, and_CC only_RB 1_CD of_IN these_DT samples_NNS was_VBD correctly_RB diagnosed_VBN by_IN Gram_NP staining_VBG ._SENT For_IN 91_CD samples_NNS from_IN T._NP vaginalis-positive_JJ patients_NNS ,_, wet-mount_NN preparations_NNS were_VBD not_RB used_VBN due_JJ to_TO the_DT lack_NN of_IN clinical_JJ symptoms_NNS ._SENT Performance_NN of_IN wet-mount_NN microscopy_NN in_IN addition_NN to_TO culture_NN increased_VBD the_DT detection_NN rate_NN from_IN 97.3_CD to_TO 100_CD %_NN ._SENT TABLE_NN 1_CD |_SYM Identification_NN of_IN T._NP vaginalis_NNS in_IN a_DT total_NN of_IN 39,585_CD individuals_NNS by_IN Gram_NP staining_VBG ,_, culture_NN on_IN MCA_NP ,_, and_CC wet-mount_NN microscopy_NN TABLE_NP 2_CD |_SYM Sensitivities_NNS of_IN different_JJ diagnostic_JJ techniques_NNS in_IN symptomatic_JJ and_CC asymptomatic_JJ individuals_NNS with_IN trichomoniasis_NN A_DT low_JJ rate_NN of_IN infection_NN with_IN trichomonads_NNS ,_, only_RB 0.5_CD %_NN ,_, was_VBD detected_VBN in_IN this_DT study_NN population_NN ,_, and_CC this_DT rate_NN is_VBZ in_IN accordance_NN with_IN observations_NNS in_IN other_JJ countries_NNS ._SENT However_RB ,_, T._NP vaginalis_NNS should_MD be_VB included_VBN in_IN STD_NN screenings_NNS ,_, not_RB only_RB because_IN it_PP is_VBZ associated_VBN with_IN gonorrhea_NN and_CC Chlamydia_NP trachomatis_NN infection_NN ,_, but_CC also_RB because_IN screening_NN for_IN T._NP vaginalis_NN is_VBZ considered_VBN an_DT achievable_JJ strategy_NN to_TO reduce_VB the_DT incidence_NN of_IN human_JJ immunodeficiency_NN virus_NN ._SENT The_DT requirements_NNS of_IN diagnostic_JJ techniques_NNS for_IN large-scale_JJ screenings_NNS with_IN respect_NN to_TO sensitivity_NN ,_, specificity_NN ,_, and_CC duration_NN of_IN test_NN results_NNS are_VBP very_RB high_JJ ._SENT Although_IN enzyme_NN immunoassays_NNS ,_, PCR_NP ,_, and_CC hybridization-based_JJ detection_NN of_IN T._NP vaginalis_NNS meet_VBP some_DT of_IN these_DT requirements_NNS ,_, performance_NN of_IN these_DT tests_NNS is_VBZ restricted_VBN to_TO specialized_JJ laboratories_NNS because_IN of_IN the_DT high_JJ costs_NNS involved_VBN ._SENT Moreover_RB ,_, these_DT tests_NNS may_MD not_RB always_RB be_VB commercially_RB available_JJ ._SENT Although_IN wet-mount_NN microscopy_NN is_VBZ a_DT cost-saving_JJ method_NN ,_, a_DT sensitivity_NN of_IN approximately_RB 40_CD to_TO 80_CD %_NN reduces_VBZ its_PP$ reliability_NN as_IN a_DT diagnostic_JJ tool_NN ._SENT The_DT data_NNS presented_VBN in_IN this_DT study_NN reveal_VB a_DT sensitivity_NN of_IN 92.8_CD %_NN for_IN wet-mount_NN microscopy_NN performed_VBN on_IN samples_NNS from_IN symptomatic_JJ patients_NNS ._SENT However_RB ,_, the_DT reliability_NN of_IN clinical_JJ symptoms_NNS is_VBZ low_JJ ,_, because_IN in_IN the_DT present_JJ study_NN as_IN many_JJ as_IN 91_CD individuals_NNS ,_, or_CC 45_CD %_NN of_IN infected_JJ patients_NNS did_VBD not_RB show_VB typical_JJ signs_NNS of_IN infection_NN ._SENT An_DT unfortunate_JJ limitation_NN of_IN this_DT study_NN due_JJ to_TO the_DT great_JJ expense_NN of_IN a_DT large-scale_JJ screening_NN is_VBZ that_IN there_EX are_VBP no_DT data_NNS available_JJ on_IN wet_JJ mount_NN results_NNS for_IN asymptomatic_JJ patients_NNS ._SENT Most_RBS likely_RB ,_, these_DT individuals_NNS harbor_VBP small_JJ numbers_NNS of_IN trichomonads_NNS and/or_CC a_DT reduction_NN in_IN ,_, or_CC loss_NN of_IN ,_, the_DT parasites_NNS '_POS motility_NN causes_VBZ a_DT negative_JJ outcome_NN with_IN this_DT test_NN ._SENT Pap_NN smears_NNS are_VBP often_RB performed_VBN in_IN gynecologic_JJ screenings_NNS and_CC have_VBP a_DT reported_VBN sensitivity_NN of_IN approximately_RB 60_CD to_TO 70_CD %_NN ._SENT However_RB ,_, an_DT error_NN rate_NN of_IN about_RB 48_CD %_NN due_JJ to_TO false-negative_JJ and_CC false-positive_JJ results_NNS has_VBZ been_VBN observed_VBN when_WRB Pap_NN smears_NNS are_VBP used_VBN as_IN the_DT only_JJ diagnostic_JJ method_NN ._SENT Staining_VBG techniques_NNS ,_, such_JJ as_IN with_IN acridine_NN orange_NN or_CC Giemsa_NP stain_NN ,_, show_NN sensitivities_NNS of_IN about_RB 60_CD and_CC 50_CD %_NN ,_, respectively_RB ,_, while_IN Gram_NP staining_VBG is_VBZ not_RB recommended_VBN to_TO diagnose_VB trichomoniasis_NN because_IN organisms_NNS may_MD appear_VB similar_JJ to_TO polymorphonuclear_JJ leukocytes_NNS ._SENT However_RB ,_, Gram-stained_NP smears_NNS are_VBP frequently_RB implemented_VBN for_IN microbiological_JJ examination_NN in_IN the_DT routine_JJ laboratory_NN ._SENT In_IN this_DT study_NN ,_, results_NNS obtained_VBN with_IN Gram_NP staining_VBG demonstrated_VBN sensitivities_NNS of_IN 89.2_CD %_NN in_IN the_DT symptomatic_JJ patient_NN and_CC 70.3_CD %_NN in_IN the_DT asymptomatic_JJ patient_NN ._SENT So_RB ,_, in_IN contrast_NN to_TO published_VBN data_NNS ,_, Gram_NP staining_VBG was_VBD equivalent_JJ to_TO the_DT wet-mount_NN or_CC Pap_NN smear_NN technique_NN and_CC may_MD as_RB well_RB be_VB substituted_VBN for_IN other_JJ diagnostic_JJ techniques_NNS if_IN immediate_JJ microscopic_JJ examination_NN is_VBZ impracticable_JJ ._SENT On_IN the_DT other_JJ hand_NN ,_, additional_JJ Gram_NP staining_VBG did_VBD not_RB significantly_RB increase_VB the_DT detection_NN of_IN T._NP vaginalis_NNS by_IN culture_NN ._SENT Finally_RB ,_, the_DT outcome_NN of_IN microscopic_JJ examinations_NNS of_IN stained_VBN smears_NNS is_VBZ subjective_JJ and_CC dependent_JJ on_IN the_DT experience_NN of_IN microscopists_NNS ,_, and_CC results_NNS need_VBP to_TO be_VB confirmed_VBN by_IN culture_NN ._SENT The_DT reported_VBN sensitivity_NN of_IN culture_NN in_IN liquid_JJ media_NNS ,_, such_JJ as_IN Diamonds_NP and_CC Trichosel_NP ,_, is_VBZ 85_CD to_TO 95_CD %_NN ._SENT The_DT most_RBS important_JJ disadvantage_NN of_IN broth_NN culture_NN is_VBZ the_DT indispensable_JJ and_CC time-consuming_JJ slide_NN preparation_NN needed_VBN for_IN identification_NN of_IN positive_JJ cultures_NNS over_IN a_DT period_NN of_IN up_IN to_TO 7_CD days_NNS ._SENT Culture_NN systems_NNS ,_, such_JJ as_IN the_DT InPouch_NP TV_NN test_NN ,_, the_DT plastic_JJ envelope_NN method_NN ,_, or_CC the_DT microtiter_NN tray_NN culture_NN described_VBN by_IN Hill_NP ,_, have_VBP been_VBN tried_VBN to_TO facilitate_VB examination_NN ._SENT Semisolid_JJ or_CC so-called_JJ pour-plate_NN culture_NN techniques_NNS to_TO isolate_VB and/or_CC quantitate_VB T._NP vaginalis_NN organisms_NNS have_VBP been_VBN described_VBN previously_RB ._SENT However_RB ,_, these_DT techniques_NNS are_VBP not_RB suitable_JJ if_IN large_JJ numbers_NNS of_IN clinical_JJ specimens_NNS are_VBP to_TO be_VB examined_VBN ._SENT MCA_NP has_VBZ been_VBN developed_VBN to_TO overcome_VB these_DT problems_NNS and_CC is_VBZ to_TO our_PP$ knowledge_NN the_DT first_JJ solid_JJ medium_NN suitable_JJ for_IN the_DT isolation_NN of_IN T._NP vaginalis_NNS from_IN clinical_JJ samples_NNS in_IN the_DT routine_JJ laboratory_NN ._SENT Data_NNS presented_VBN in_IN this_DT study_NN reveal_VBP that_IN MCA_NP has_VBZ a_DT sensitivity_NN of_IN 98.5_CD %_NN in_IN detection_NN of_IN T._NP vaginalis_NNS in_IN a_DT low-risk_JJ population_NN comprising_VBG symptomatic_JJ as_RB well_RB as_IN asymptomatic_JJ patients_NNS ._SENT The_DT in_IN vitro_NN experiment_NN demonstrated_VBN MCA_NP to_TO be_VB superior_JJ to_TO broth_NN culture_NN in_IN detecting_VBG low_JJ numbers_NNS of_IN trichomonads_NNS ,_, confirming_VBG the_DT results_NNS of_IN this_DT study_NN ._SENT Compared_VBN to_TO broth_NN culture_NN ,_, the_DT agar_NN plate_NN technique_NN reduces_VBZ the_DT risk_NN of_IN missing_VBG positive_JJ specimens_NNS by_IN making_VBG possible_JJ the_DT microscopic_JJ examination_NN of_IN the_DT whole_JJ clinical_JJ material_NN obtained_VBD ._SENT This_DT solid_JJ medium_NN is_VBZ a_DT timesaving_JJ culture_NN technique_NN because_IN it_PP eliminates_VBZ the_DT need_NN for_IN slide_NN preparations_NNS ,_, and_CC it_PP is_VBZ favorable_JJ for_IN screening_VBG a_DT low-risk_JJ population_NN if_IN more_JJR than_IN one_CD sample_NN is_VBZ inoculated_VBN onto_IN a_DT single_JJ plate_NN ._SENT Since_IN wet-mount_NN and_CC stained-smear_NN methods_NNS show_VBP low_JJ sensitivities_NNS for_IN detection_NN in_IN asymptomatic_JJ individuals_NNS ,_, culture_NN of_IN T._NP vaginalis_NNS can_MD be_VB recommended_VBN as_IN the_DT only_JJ diagnostic_JJ method_NN for_IN this_DT patient_JJ group_NN and_CC should_MD therefore_RB not_RB be_VB replaced_VBN by_IN these_DT tests_NNS ._SENT However_RB ,_, this_DT culture_NN technique_NN has_VBZ a_DT turnaround_NN time_NN of_IN 2_CD to_TO 6_CD days_NNS ._SENT Sometimes_RB rapid_JJ tests_NNS ,_, such_JJ as_IN enzyme_NN immunoassays_NNS or_CC PCR_NP ,_, are_VBP preferred_JJ ._SENT An_DT evaluation_NN of_IN the_DT methods_NNS and_CC MCA_NP will_MD have_VB to_TO be_VB carried_VBN out_RP in_IN the_DT future_NN ._SENT In_IN summary_NN ,_, MCA_NP performed_VBD as_IN a_DT highly_RB sensitive_JJ ,_, reliable_JJ ,_, and_CC easy-to-handle_NN culture_NN technique_NN in_IN the_DT routine_JJ laboratory_NN for_IN diagnosis_NN of_IN T._NP vaginalis_NN infections_NNS in_IN clinical_JJ samples_NNS from_IN symptomatic_JJ as_RB well_RB as_IN asymptomatic_JJ individuals_NNS and_CC may_MD provide_VB a_DT suitable_JJ screening_NN method_NN for_IN trichomoniasis_NN ._SENT 